Budwig Diet Revision –
by
Duncan Crow, Wholistic Consultant
This is a direct
quote from the site of Duncan Crow
Germany's Dr.
Joanna Budwig is widely credited for discovering that 2 simple food
items, cold-pressed flax seed oil and low-fat cottage cheese, will
cure or prevent many forms of cancer and a long list of other
degenerative diseases including cardiovascular diseases and skin
diseases. But the 50-year old "Budwig Diet" is long in the tooth
and newer data has emerged that shows where we can improve on it. (essential
fatty acids references)
Sulfur-rich
protein and calcium in the "Budwig protocol" is provided by cottage
cheese. Because many people can not take "dairy", let’s look more
closely at the cottage cheese. Human milk is higher in whey and much
lower in casein than cow milk or goat milk; casein is the main protein
in cheese and cottage cheese. Caseins differ somewhat; cow milk
contains a lot of alpha-casein, which because of its different
properties is the main cause of milk and "dairy" indigestion in
humans. Beta lactoglobulins in cow milk can also be problematic as
allergens, and cow milk also contains more alpha s1-casein than goat
milk. All of this explains why many people find goat milk less
problematic than cow milk.
The problematic
milk components can be removed leaving low-fat whey, most of which is
an exact match across the whole mammalian order. The common
ingredients are more easily assimilated than any other protein and do
not produce sensitivity or allergy issues. The Physicians Desktop
Reference for Prescription Drugs lists one pure whey isolate as
"well-tolerated by even severely milk-sensitive individuals", and
practice corroborates that.
Bottom line -
although biological incompatibilities exist in foreign milk, comments
that lump 'dairy' products together as problematic are sloppy; the
statement does not apply to high-quality whey, and it is widely
acknowledged to be the most healthy fraction of milk.
The Budwig Diet
revision uses undenatured whey instead of cottage cheese. Undenatured
whey contains the sulfur-containing amino acids methionine and
cysteine compounds including cystine. Methionine is transformed into
cysteine by the liver. Cellular cysteine is the rate-limiting factor
in production of glutathione, the body's master antioxidant and
detoxifier. Glutathione is crucial to life; it's involved in ATP
energy generation, immune system support, liver and other organ
support, reducing toxin load and oxidative stress, and importantly, it
shrinks tumors when levels are maintained. More glutathione
information including the role whey can play in cancer therapy is
available here with
glutathione references.
Cottage cheese
doesn't boast those benefits; in fact it's only a sulfur amino acid
source. The Budwig Diet revision's replacement of the bio-incompatible
cottage cheese with compatible cold-processed whey adheres to the
principles of the "Budwig Diet", and will provide huge additional
benefit. Unlike cottage cheese, cold-processed whey is mildly
alkalizing to the body, and several cold-processed wheys are listed in
the US PDR as a specific anti-cachexia (anti-wasting) formula.
The flaxseed oil
in the original plan provides the essential fatty acid alpha-linolenic
acid (ALA), which is thought to be a 'good' omega-3 oil; however,
more recent science has revealed that it's a common but faulty
assumption that ALA is physiologically equivalent to omega-3 essential
fatty acids EPA and DHA, and that there is no known need for alpha-linolenic
acid (ALA) independent of its conversion to EPA/DHA. And in adults the
conversion rate is tiny; the
US Environmental Protection Agency
has posted
this powerpoint presentation (slide
5) that explains less than 1% conversion of ALA to EPA (some
sources say somewhat higher), and <0.01% to DHA. (People, this
is HUGE – we’ve been hoodwinked too long!)
Though these
details have traditionally escaped the followers of Joanna Budwig and
Udo Erasmus, fatty acids expert Dr. Floyd Chilton fully explains
them in his book Inflammation Nation. Chilton says (page 97), "I wish
I could tell you that the (ALA)
in flaxseed oil could replace wild fish as a rich source of EPA and
DHA but the scientific literature simply does not support this
contention. ...We do the conversion but very slowly, and we also eat a
lot of fatty acids such as LA that 'compete' for enzymes that convert
ALA to EPA and DHA, further limiting its conversion."
This competition
is most pronounced in the common condition of low EPA/DHA and higher
omega-6 fatty acid intake seen in the modern diet. Thus the omega-6
content of the flax oil, (25% of the amount of ALA) seen in the table
below, also inhibits the conversion.
Composition of
flax seed oil
|
Fatty acid |
Percent |
|
Alpha
linolenic (omega-3) |
55 |
|
Linoleic
(omega-6) |
13.8 |
|
Oleic |
21.5 |
|
Stearic |
2.2 |
|
Palmitic
(saturated) |
7.1 |
Budwig and her
followers including Udo Erasmus also purport to supply the needed
fatty acids to rebuild cell walls so they can carry more oxygen and
etc., by supplying ALA;
however, cell walls actually contain negligible ALA and are high EPA
and DHA.
This explains
why for more than maintenance you may need vastly more EPA and DHA
than an
ALA supplement
can provide, and why fish oil supplements are more popular for
inflammation.
For these reasons flax oil seems a less brilliant choice for
biological support in humans than it did 50 years ago.
Unlike ALA, EPA
and DHA are essential to health and can reverse illness, including the
coronary heart disease, skin disorders and cancer claimed by
proponents of the Budwig Diet.
The Budwig Diet revision ensures adequate EPA and DHA are supplied.
Wild salmon oil, wild fish oil, and cod liver oil provide lots of EPA
and DHA. Wild salmon oil, even minimally refined oil, has almost no
impurities. Inflammation can be further reduced by adding GLA or
Borage oil.
Some people may
feel safer by staying closer to the original diet by adding these EFAs
rather than replacing the flax oil of the original Budwig diet, but it
is unwise to not include them at all, thus this Budwig Diet revision
was probably inevitable.
Essential Fatty
Acids References:
"Specific
inhibitory effect of dietary eicosapentaenoic acid on N-nitroso-N-methylurea-induced
mammary carcinogenesis in female Sprague-Dawley rats" (Carcinogenesis;
11(11): 2015-9, Nov 1990) found that EPA significantly reduced (60%
versus 93.3%) mammary tumour incidence and number in rats and
significantly reduced prostaglandin levels, suggesting that the breast
cancer inhibition by EPA may be mediated via lipid metabolism and
associated reduction in prostaglandin synthesis.
Omega-3 fatty
acids from fish oil significantly reduced weight loss and tumour
growth rate in an experimental colon cancer cachexia system in this
study: (Tisdale MJ and Dhesi JK. Inhibition of weight loss by omega-3
fatty acids in an experimental cachexia model. Cancer Res; 50(16):
5022-6. Aug 15 1990)
"Anticachectic
and antitumor effect of eicosapentaenoic acid and its effect on
protein turnover" (Cancer Res; 51(22): 6089-93. Nov 15 1991) studied
the effect of eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA)
on weight loss and tumour growth in mice with cachexia-inducing colon
cancer. EPA inhibited both weight loss and tumour growth rate in a
dose-related manner; body weight was effectively maintained (weight
loss did not occur even when tumour growth resumed), there was delay
in tumour progression of growth, and overall survival was
approximately doubled in EPA-treated acids, were equally efffective in
inhibiting growth of these same prostate cancer cells in a
dose-dependent manner, with a 65% reduction in growth.
In the small double-blind,
placebo-controlled study, "Effect of omega-3 fatty acids on rectal
mucosal cell proliferation in subjects at risk for colon cancer",
(Gastroenterology; 103(3): 1096-8. Sep 1992) 20 patients with sporadic
adenomatous colorectal polyps were given omega-3 fatty acid
supplementation for 12 weeks. While there was no change in the
controls, the group of 10 that received fish oil containing EPA and
DHA the "S"-phase cells (a reliable marker of colon cancer risk)
significantly dropped in 2 weeks and stayed lower throughout the
trial. Arachidonic acid (inflammatory) levels also decreased.
|